Annual report pursuant to Section 13 and 15(d)

Equity (Tables)

v3.22.1
Equity (Tables)
12 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of stock options outstanding
  Options Outstanding       Options Exercisable  
  Range of
Exercise
Price
      Number
Outstanding at
December 31,
2021
      Weighted
Average
Remaining
Contractual Life
(Years)
      Weighted
Average
Exercise
Price
      Number
Exercisable at
December 31,
2021
     

Weighted
Average
Exercise
Price

 
$ 0.50       2,000,000       5.11     $ 0.50       2,000,000     $ 0.50  
  1.00 – 1.93       2,955,000       4.80       1.39       2,749,166       1.41  
  2.00 – 2.80       2,740,000       1.76       2.17       2,740,000       2.17  
  4.76       30,000       2.26       4.76       30,000       4.76  
$ 0.50 – 4.76       7,725,000       3.97     $ 1.45       7,519,166     $ 1.46  

 

Schedule of stock option activities
    Number of
Options
    Weighted
Average
Exercise
Price
 
Outstanding at January 1, 2020     5,260,000     $ 1.45  
Granted     1,960,000       1.52  
Expired     (80,000 )     (1.00 )
Outstanding at December 31, 2020     7,140,000       1.48  
Granted     860,000       1.08  
Forfeited / Expired     (275,000 )     (1.01 )
Outstanding at December 31, 2021     7,725,000     $ 1.45  
Options exercisable at December 31, 2021     7,519,166     $ 1.46  
Options expected to vest     205,834     $ 1.04  

 

Schedule of company’s nonvested stock options granted
    Number of
Options
    Weighted
Average
Exercise
Price
 
Nonvested at January 1, 2020     264,723     $ 2.00  
Granted     1,960,000       1.52  
Vested     (2,006,389 )     (1.62 )
Nonvested at December 31, 2020     218,334       1.18  
Granted     860,000       1.08  
Forfeited     (15,000 )     (1.11 )
Vested     (857,500 )     (1.11 )
Nonvested at December 31, 2021     205,834     $ 1.04